Fondsfinans Global Helse is an actively managed global equity fund with history going back to 2000. Its management company, Fondsfinans Kapitalforvaltning, is an Oslo-based manager established as a separate asset management business in 1997 and wholly owned by MUST AS.
Investment philosophy
The mandate limits the fund to large, liquid listed companies in pharmaceuticals, biotechnology, medical equipment and services. The objective is risk-adjusted return, and risk awareness recurs across the team's other funds.
The managers
Preben Bang manages the fund from Oslo and has done so since 2022. He is mentioned together with Melanie Brooks and Fredrik Aarum as a management team. Bang holds a master's degree in physics and mathematics, is a CFA charterholder and certified interest rate analyst, and has a background in risk management and quantitative analysis at NBIM. He also manages Fondsfinans Global Utbytte and Fondsfinans Aktiv 60/40.
The portfolio
The portfolio has a lasting emphasis on pharmaceuticals and biotechnology, with large companies such as Roche, Johnson & Johnson and Eli Lilly among the steady top holdings. The fund has fluctuated less than comparable funds.
FundTelligence description · 18/10/2026
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.
7 of 18 funds ranked on a calculated return
#3/ 18Year to date
+15.71% NOK
as of 13 Nov 2026 · NOK class
About the figures
13 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#3/ 221 year
+19.23% NOK
as of 13 Nov 2026 · NOK class
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#9/ 223 years (ann.)
+8.06% NOK
as of 13 Nov 2026 · NOK class
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#10/ 225 years (ann.)
+7.35% NOK
as of 13 Nov 2026 · NOK class
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
Comparison basis
Year to date
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
1 year
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
3 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
5 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.